sickle

The U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in patients with sickle cell disease.The approval comes about a decade…

Improved sickle cell disease outcomes are possible if governments and health…

Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease (SCD) and beta thalassemia. These two common life-threatening anemias afflict millions of individuals…

Davenport, Iowa, June 19, 2023 (GLOBE NEWSWIRE) -- (View news release online) On Juneteenth, ImpactLife is sharing resources to emphasize the importance of diversity within communities…

Data from two pivotal trials suggest that a single infusion of the CRISPR-based…

Elana Gotkine MONDAY, June 5, 2023 (HealthDay News) -- For persons with sickle cell disease (SCD), gene therapy seems not to be cost-effective…

Sickle cell disease (SCD) was associated with four-fold increased risk of…

Gene therapy may not be cost-effective in treating patients with sickle cell…

Dennis Thompson WEDNESDAY, May 31, 2023 (HealthDay News) -- An exceptionally pricey gene therapy cure for sickle cell disease could soon be…

The NHS is introducing a new genetic blood-matching test to help people with sickle cell disease or thalassemia be more accurately matched to donors for blood transfusions, It will be the…